Pfizer prevails in Rost whistleblower suit

After several years of legal sparring, a federal judge has dismissed the whistleblower lawsuit that controversial Pfizer exec Peter Rost filed against the company, alleging that it had marketed Genotropin, a human growth hormone, for unapproved uses. Report

Suggested Articles

While Lilly's 2018 launch Emgality is approved to prevent migraines, Reyvow is intended to treat them as they occur.

ICER's new draft review of RA drugs takes a different approach, reflecting how physicians treat the disease and the time horizon that's considered.

Johnson & Johnson is facing multibillion-dollar liabilities in thousands of talc and opioid cases. But that's not such a bad thing, one analyst said.